OBJECTIVE: A significant proportion of breast cancer patients experiences psychiatric morbidity in the first year after a breast cancer diagnosis and/or beginning of treatment. This study attempted to identify and understand the risk factors for developing such problems. METHODS: A consecutive series of 87 patients, aged 40-75 years, was assessed prior to diagnosis of breast cancer and followed-up approximately 8 weeks after beginning of cancer treatment and again 9 months after first follow-up. Assessments included measures of psychiatric morbidity using the General Health Questionnaire (GHQ-12), coping style using the Mental Adjustment to Cancer (MAC) Scale, symptom attribution, beliefs about breast cancer, social support, socio-demographic and clinical variables. RESULTS: A total of 85.1% of patients completed both follow-ups. Pre-diagnostically, 32.2% of breast cancer patients scored as a GHQ-12 'case.' GHQ scores fell significantly between pre-diagnostic and both post-diagnostic assessments, especially in women who had thought they had cancer. Predictors of psychological morbidity at first follow-up included pre-diagnostic GHQ-12 score, lack of social support and feelings of 'personal responsibility/avoidance.' GHQ-12 'caseness' at second follow-up was predicted by lack of social support alone. CONCLUSIONS: Overall, psychiatric morbidity is higher prior to, than following, a definitive diagnosis of breast cancer. Early reactions of this kind are predictive of post-treatment adjustment. However, only the presence of social support in this study seems to be associated with successful adjustment in the first year following a breast cancer diagnosis. Women at increased risk of psychological morbidity after a breast cancer diagnosis may be thus identifiable and targeted therapeutically.
OBJECTIVE: A significant proportion of breast cancerpatients experiences psychiatric morbidity in the first year after a breast cancer diagnosis and/or beginning of treatment. This study attempted to identify and understand the risk factors for developing such problems. METHODS: A consecutive series of 87 patients, aged 40-75 years, was assessed prior to diagnosis of breast cancer and followed-up approximately 8 weeks after beginning of cancer treatment and again 9 months after first follow-up. Assessments included measures of psychiatric morbidity using the General Health Questionnaire (GHQ-12), coping style using the Mental Adjustment to Cancer (MAC) Scale, symptom attribution, beliefs about breast cancer, social support, socio-demographic and clinical variables. RESULTS: A total of 85.1% of patients completed both follow-ups. Pre-diagnostically, 32.2% of breast cancerpatients scored as a GHQ-12 'case.' GHQ scores fell significantly between pre-diagnostic and both post-diagnostic assessments, especially in women who had thought they had cancer. Predictors of psychological morbidity at first follow-up included pre-diagnostic GHQ-12 score, lack of social support and feelings of 'personal responsibility/avoidance.' GHQ-12 'caseness' at second follow-up was predicted by lack of social support alone. CONCLUSIONS: Overall, psychiatric morbidity is higher prior to, than following, a definitive diagnosis of breast cancer. Early reactions of this kind are predictive of post-treatment adjustment. However, only the presence of social support in this study seems to be associated with successful adjustment in the first year following a breast cancer diagnosis. Women at increased risk of psychological morbidity after a breast cancer diagnosis may be thus identifiable and targeted therapeutically.
Authors: Marianna Kyranou; Kathleen Puntillo; Laura B Dunn; Bradley E Aouizerat; Steven M Paul; Bruce A Cooper; John Neuhaus; Claudia West; Marylin Dodd; Christine Miaskowski Journal: Cancer Nurs Date: 2014 Nov-Dec Impact factor: 2.592
Authors: Lois C Friedman; Catherine R Barber; Jenny Chang; Yee Lu Tham; Mamta Kalidas; Mothaffar F Rimawi; Mario F Dulay; Richard Elledge Journal: J Cancer Educ Date: 2010-02-26 Impact factor: 2.037
Authors: Marianna Kyranou; Kathleen Puntillo; Bradley E Aouizerat; Laura B Dunn; Steven M Paul; Bruce A Cooper; Claudia West; Marylin Dodd; Charles Elboim; Christine Miaskowski Journal: J Appl Biobehav Res Date: 2014-06
Authors: Anava A Wren; Rebecca A Shelby; Mary Scott Soo; Zenzi Huysmans; Jennifer A Jarosz; Francis J Keefe Journal: Support Care Cancer Date: 2019-01-31 Impact factor: 3.603
Authors: Lois C Friedman; Catherine Romero; Richard Elledge; Jenny Chang; Mamta Kalidas; Mario F Dulay; Garrett R Lynch; C Kent Osborne Journal: J Behav Med Date: 2007-05-12
Authors: Julie B Schnur; Guy H Montgomery; Michael N Hallquist; Alisan B Goldfarb; Jeffrey H Silverstein; Christina R Weltz; Alexis V Kowalski; Dana H Bovbjerg Journal: Int J Behav Med Date: 2008 Jan-Mar
Authors: Anna P B M Braeken; Lilian Lechner; Francis C J M van Gils; Ruud M A Houben; Daniëlle Eekers; Ton Ambergen; Gertrudis I J M Kempen Journal: BMC Cancer Date: 2009-06-09 Impact factor: 4.430